Last reviewed · How we verify

NCT07392593

Physical Activity as a Non-Invasive Strategy to Address Obesity and Musculoskeletal Risk in First-Year University Students: A Cross-Sectional Study in Spain

Completed Last updated 6 February 2026
What this trial tests

trial in Physical Inactivity in 821 participants. Completed in 1 June 2024.

Timeline
1 September 2023
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorUniversidad Rey Juan Carlos
StatusCompleted
Study typeOBSERVATIONAL
Enrollment821
Start date1 September 2023
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Spain

Conditions studied

Sponsor

Universidad Rey Juan Carlos — full company profile →

Who can join

18 and older, any sex, with Physical Inactivity or Sedentary Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this retrospective cross-sectional study was to assess physical activity and sedentary behavior levels in first-year university students and to explore their association with obesity and musculoskeletal health risk indicators. Physical activity and sedentary behavior were assessed using the Global Physical Activity Questionnaire (GPAQ), while body mass index (BMI) was used to classify weight status. Sedentary behavior was interpreted as an indirect indicator of musculoskeletal risk. Understanding these behavioral patterns may help identify at-risk profiles and inform non-invasive prevention strategies in university populations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Inactivity

Currently open trials in the same condition.

Other Universidad Rey Juan Carlos trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07392593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing